Lp(a) measurement bias
Over and underestimation of Lp(a) due to its different molecular weight isoforms has led to bias in many studies leading to underestimation of its strength as a cardiovascular risk factor.
Dr Michael France is a Chemical Pathologist with a specialist interest in Lipidology and will present at the HEART UK virtual conference on 7 July.
He has worked with HEART UK in producing consensus guidelines for management of homozygous familial hypercholesterolaemia and Lipoprotein (a) testing. He has published widely in the field of Lipidology and Clinical Biochemistry and has a particular interest in the diagnostic utility of laboratory tests.
See the full conference programme on the Health professionals section of the website. The Health Professional area of the website is intended only for healthcare professionals.
This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies
Related stories
- Saving the PASS system for the sake of England’s FH Services, for current and future generations
- The national Child Parent Screening Service (CPSS) pilot has been extended until October 2024
- Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
- how the NHS is working to deliver improved lipid management
- HEART UK 36th Annual Medical and Scientific Conference 2023 LIPIDS – THE BEST YET - CONFERENCE REVIEW
- Our new Lipidology Podcast
- Recently formed Lipoprotein(a) Taskforce publishes Call to Action to increase recognition and acceptance of Lp(a) as an ASCVD risk factor
- Lipoprotein (a) disorder gets SNOMED codes
- Would you like to update your knowledge of lipid management and have the opportunity to liaise with others working in this area?
- Familial Hypercholesterolaemia Gene Testing One-Day Online Workshop - Dates for 2023